Search

Your search keyword '"Dawson, Peter"' showing total 554 results

Search Constraints

Start Over You searched for: Author "Dawson, Peter" Remove constraint Author: "Dawson, Peter" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
554 results on '"Dawson, Peter"'

Search Results

2. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

7. Acoustic characterisation of the roughness of reflective surfaces

11. Temporal trends in test-seeking behaviour during the COVID-19 pandemic

13. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

22. Optical - Near Infrared Photometric Calibration of M-dwarf Metallicity and Its Application

23. On the analysis of livestock networks and the modelling of foot-and-mouth disease

25. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

28. Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial

29. A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

31. PDX1LOW MAFALOW β-cells contribute to islet function and insulin release

32. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

34. Referee Abuse, Intention to Quit, and Well-Being.

37. The Sierra Leone Trial to Introduce a Vaccine Against Ebola : An Evaluation of rVSVΔG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak

39. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola

40. Health Conditions in an Adult Population in Sierra Leone : Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)

41. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic : The Sierra Leone Trial to Introduce a Vaccine Against Ebola

42. Pilonidal Disease

43. Introduction to Occlusion

44. Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101

45. Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study

46. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

47. Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research

48. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Catalog

Books, media, physical & digital resources